Prevalence and factors associated with anemia in patients with heart failure in Sub-saharan Africa, Cameroon - 06/01/20
, C.A. Pieme 1, C. Dongmo Nanfack-Géondo 3, D.L. Wouna Angong 3, B. Hamadou 1, 2, S.L.E. Ndongo Amougou 1, 4, J. Boombhi 1, 5, L. Kuate Mfeukeu 1, 2, E.W. Pefura Yone 1, 6, A.P. Menanga 1, 5
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Résumé |
Background |
Heart failure has several comorbidities including anemia which is an independent factor of mortality and hospitalization but data on the topic are scarce in our context.
Purpose |
We aimed to determine the prevalence and determinants of anemia in heart failure.
Methodology |
We conducted a cross-sectional study from January to April 2018. Anemia was defined as hemoglobin <12g/dl in women and <13g/dl in men. Light anemia was defined as hemoglobin in the range of 10 to 11.9g/dl in women and 10 to 12.9g/dl in men. Moderate anemia and severe anemia were respectively defined by a hemoglobin level of between 8 and 9.9g/dl and then below 8g/dl in men and women.
Results |
We included 109 (55% female) patients in our study. The median age [interquartile range] was 65 [54–73] years. The mean hemoglobin level was 12.28±1.89g/dl, 12.73±1.92g/dl in men and 11.91±1.81g/dl in women (P=0.054). The prevalence (95% confidence interval) of anemia was 49.5% (40.4–58.7) with 51% (36.7–65.3) in men and 48.3% (35–61.7) in women (P=0.848). About 82.4% of patients had mild anemia, 17.6% moderate anemia and 5.6% severe anemia. The determinant of anemia [odds ratio, (95% CI)] was the treatment by ACE inhibitors [5.8, (1.6-20.7); P=0.007].
Conclusion |
Anemia is an important and frequent comorbidity in heart failure in our context.
Le texte complet de cet article est disponible en PDF.Plan
Vol 12 - N° 1
P. 51-52 - janvier 2020 Retour au numéro
Article précédent
- Increased mortality associated with cardiac amyloidosis among patients with unexplained left ventricular hypertrophy
- J. Inamo, J. Lassus, N. Ozier-Lafontaine, A. Atallah, A. Monfort, R. Banydeen
- How to differentiate infective from physiologic 18F-Fluorodeoxyglucose positron emission tomography uptake pattern in left prosthetic heart valve?
- R. San, P. Lim, E. Itti
Bienvenue sur EM-consulte, la référence des professionnels de santé.